is one of the most influential guidance documents in the pharmaceutical and biotechnology industries concerning container closure integrity (CCI). Published by the PDA, a leading global association providing science and technology information for the pharmaceutical and biopharmaceutical communities, this report serves as a foundational reference for evaluating the sterility and stability of packaging systems.
When you purchase the official PDF, you receive a watermarked copy with your organization’s name, which is acceptable during FDA audits. pda technical report 27 pdf
PDA Technical Report No. 27 provides a comprehensive framework for ensuring container/closure integrity, emphasizing a lifecycle approach to prevent sterilization failures. The report guides manufacturers in selecting appropriate test methods, such as vacuum decay, to evaluate the barrier qualities of sterile packaging. For more information, visit Parenteral Drug Association Technical Report No. 27: Pharmaceutical Package Integrity is one of the most influential guidance documents
It represents the "turning point" where the industry began moving away from "Did we see a leak?" to "What is the probability of a leak?" PDA Technical Report No
The report stresses that – method selection must be risk-based and product-specific.